Parkinson's Disease And Movement Disorders News

This story comes from the Fall 2024 edition of Coming Down The Pipeline: What's new & next at the DCRI, and the people making it happen sent out on December 11, 2024. Learn more about the DCRI on their website.

More than half of patients who develop Parkinson’s Disease (PD) have a history of complaints related to the gastrointestinal (GI) system, such as chronic nausea or constipation.

Andy Liu, MD, Kim Johnson, MD, and Burt Scott, MD, PhD were recipients of this year's Michelle P. Winn Inclusive Excellence Award.

The following is a proclamation by Governor Cooper stating May 2024 is to be observed as Huntington's Disease Awareness Month. View the proclamation on the official state website.

In January, members of Duke Neurology wrote and contributed to 20 peer-reviewed journal articles. This month’s research includes an article reviewing interneuron transplantation for drug-resistant epilepsy, a study on the relationship between BMI and intracerebral hemorrhage, and a study indicating that genetic associations with longevity are stronger in females than in males. 

Dr. Mitchell discusses DBS patient outcomes from a recent study using an experimental treatment model. 

The final month of 2023 saw members of the Duke Neurology Department contributing to nine new peer-reviewed journal articles. Highlights include an analysis of symptoms associated with internal tremor for Parkinson’s disease, a trio of population-level studies for stroke, and a new examination of the connections between white matter and executive function. Read short summaries of each of these articles and find links to the original research below.

What do a speech prosthetic that translates brain signals into speech, retinal scans that detect cognitive impairment, and a promising new form of genetic therapy for Parkinson’s and some forms of dementia have in common? They’re all examples of the 21 peer-reviewed journal articles authored members of the Duke Neurology Department published this November.  

Silas Buck, PhD, first fell in love with neuroscience during the earliest days of his undergraduate career, when he became fascinated with the complex biological reactions that were responsible for even his earliest lab experiments. Buck pursued this passion through graduate school, studying how dopamine neurons become vulnerable to degeneration in Parkinson’s disease.